Annual Total Liabilities
$29.99 M
+$2.13 M+7.64%
31 December 2023
Summary:
Cytosorbents annual total liabilities is currently $29.99 million, with the most recent change of +$2.13 million (+7.64%) on 31 December 2023. During the last 3 years, it has risen by +$19.25 million (+179.33%). CTSO annual total liabilities is now at all-time high.CTSO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$34.80 M
-$1.89 M-5.14%
30 September 2024
Summary:
Cytosorbents quarterly total liabilities is currently $34.80 million, with the most recent change of -$1.89 million (-5.14%) on 30 September 2024. Over the past year, it has increased by +$5.74 million (+19.76%). CTSO quarterly total liabilities is now -5.14% below its all-time high of $36.69 million, reached on 30 June 2024.CTSO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.6% | +19.8% |
| 3 y3 years | +179.3% | +42.3% |
| 5 y5 years | +73.7% | +58.6% |
CTSO Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +179.3% | -5.1% | +50.5% |
| 5 y | 5 years | at high | +179.3% | -5.1% | +240.6% |
| alltime | all time | at high | +3206.4% | -5.1% | >+9999.0% |
Cytosorbents Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $34.80 M(-5.1%) |
| June 2024 | - | $36.69 M(+30.4%) |
| Mar 2024 | - | $28.14 M(-6.1%) |
| Dec 2023 | $29.99 M(+7.6%) | $29.99 M(+3.2%) |
| Sept 2023 | - | $29.06 M(+2.5%) |
| June 2023 | - | $28.35 M(-0.6%) |
| Mar 2023 | - | $28.51 M(+2.3%) |
| Dec 2022 | $27.86 M(+3.4%) | $27.86 M(+20.4%) |
| Sept 2022 | - | $23.13 M(-2.2%) |
| June 2022 | - | $23.65 M(-15.1%) |
| Mar 2022 | - | $27.84 M(+3.4%) |
| Dec 2021 | $26.94 M(+151.0%) | $26.94 M(+10.2%) |
| Sept 2021 | - | $24.46 M(+2.7%) |
| June 2021 | - | $23.81 M(+132.9%) |
| Mar 2021 | - | $10.22 M(-4.8%) |
| Dec 2020 | $10.73 M(-55.2%) | $10.73 M(-55.4%) |
| Sept 2020 | - | $24.05 M(-3.6%) |
| June 2020 | - | $24.94 M(+8.8%) |
| Mar 2020 | - | $22.91 M(-4.4%) |
| Dec 2019 | $23.96 M(+38.8%) | $23.96 M(+9.2%) |
| Sept 2019 | - | $21.95 M(+29.6%) |
| June 2019 | - | $16.94 M(+6.0%) |
| Mar 2019 | - | $15.98 M(-7.4%) |
| Dec 2018 | $17.26 M(+24.7%) | $17.26 M(+21.7%) |
| Sept 2018 | - | $14.18 M(+5.9%) |
| June 2018 | - | $13.38 M(-3.4%) |
| Mar 2018 | - | $13.86 M(+0.1%) |
| Dec 2017 | $13.84 M(+65.6%) | $13.84 M(+8.6%) |
| Sept 2017 | - | $12.74 M(-10.1%) |
| June 2017 | - | $14.17 M(+43.7%) |
| Mar 2017 | - | $9.86 M(+18.0%) |
| Dec 2016 | $8.36 M(+174.5%) | $8.36 M(-11.8%) |
| Sept 2016 | - | $9.48 M(+7.5%) |
| June 2016 | - | $8.81 M(+171.3%) |
| Mar 2016 | - | $3.25 M(+6.7%) |
| Dec 2015 | $3.04 M | $3.04 M(-11.7%) |
| Sept 2015 | - | $3.45 M(+36.4%) |
| June 2015 | - | $2.53 M(-59.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $6.20 M(+37.6%) |
| Dec 2014 | $4.51 M(-75.4%) | $4.51 M(-77.9%) |
| Sept 2014 | - | $20.42 M(-0.3%) |
| June 2014 | - | $20.49 M(+4.3%) |
| Mar 2014 | - | $19.65 M(+7.3%) |
| Dec 2013 | $18.31 M(+22.4%) | $18.31 M(+3.8%) |
| Sept 2013 | - | $17.65 M(+9.2%) |
| June 2013 | - | $16.17 M(+11.8%) |
| Mar 2013 | - | $14.46 M(-3.3%) |
| Dec 2012 | $14.96 M(+22.5%) | $14.96 M(+620.9%) |
| Sept 2012 | - | $2.08 M(-9.9%) |
| June 2012 | - | $2.30 M(+2.5%) |
| Mar 2012 | - | $2.25 M(-81.6%) |
| Dec 2011 | $12.21 M(+431.8%) | $12.21 M(+573.5%) |
| Sept 2011 | - | $1.81 M(-6.8%) |
| June 2011 | - | $1.95 M(+12.8%) |
| Mar 2011 | - | $1.72 M(-24.9%) |
| Dec 2010 | $2.30 M(+136.6%) | $2.30 M(+12.7%) |
| Sept 2010 | - | $2.04 M(+66.4%) |
| June 2010 | - | $1.22 M(-7.3%) |
| Mar 2010 | - | $1.32 M(+36.1%) |
| Dec 2009 | $970.80 K(-5.5%) | $970.80 K(+6.0%) |
| Sept 2009 | - | $915.80 K(-0.4%) |
| June 2009 | - | $919.80 K(+3.0%) |
| Mar 2009 | - | $893.10 K(-13.1%) |
| Dec 2008 | $1.03 M(+13.3%) | $1.03 M(+4.6%) |
| Sept 2008 | - | $982.50 K(-19.9%) |
| June 2008 | - | $1.23 M(-0.9%) |
| Mar 2008 | - | $1.24 M(+36.5%) |
| Dec 2007 | $906.90 K(-16.2%) | $906.90 K(+4.0%) |
| Sept 2007 | - | $872.40 K(-43.0%) |
| June 2007 | - | $1.53 M(+6.7%) |
| Mar 2007 | - | $1.43 M(+32.6%) |
| Dec 2006 | $1.08 M | $1.08 M(-54.9%) |
| Sept 2006 | - | $2.40 M(-34.9%) |
| June 2006 | - | $3.69 M(+3235.0%) |
| Feb 2006 | - | $110.50 K(+8.3%) |
| Nov 2005 | - | $102.00 K(+8.6%) |
| Aug 2005 | - | $93.90 K |
FAQ
- What is Cytosorbents annual total liabilities?
- What is the all time high annual total liabilities for Cytosorbents?
- What is Cytosorbents annual total liabilities year-on-year change?
- What is Cytosorbents quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cytosorbents?
- What is Cytosorbents quarterly total liabilities year-on-year change?
What is Cytosorbents annual total liabilities?
The current annual total liabilities of CTSO is $29.99 M
What is the all time high annual total liabilities for Cytosorbents?
Cytosorbents all-time high annual total liabilities is $29.99 M
What is Cytosorbents annual total liabilities year-on-year change?
Over the past year, CTSO annual total liabilities has changed by +$2.13 M (+7.64%)
What is Cytosorbents quarterly total liabilities?
The current quarterly total liabilities of CTSO is $34.80 M
What is the all time high quarterly total liabilities for Cytosorbents?
Cytosorbents all-time high quarterly total liabilities is $36.69 M
What is Cytosorbents quarterly total liabilities year-on-year change?
Over the past year, CTSO quarterly total liabilities has changed by +$5.74 M (+19.76%)